Gonzalez, M., Akkooi, A. C. J. V., Bennett, T., Ch'ng, S., Shannon, K. F., Rtshiladze, M. A., Scolyer, R. A., Rawson, R. V., Osorio, M., Kapoor, R., Hsiao, E., Rizos, H., Lo, S. N., Menzies, A. M., Hong, A. M., Long, G. V., Silva, I. E. D. P. D. (2025). A phase 2 study to determine the clinical and pathological (path) response to neoadjuvant nivolumab (nivo) and relatlimab (rela) in stage II to IV (M0) resectable cutaneous squamous cell carcinoma (Neo-SCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps9610